Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma

BACKGROUND: Neuroblastoma currently has poor prognosis, therefore we proposed a new strategy by targeting neuroblastoma with genetically engineered anaerobic Salmonella (Sal-YB1). METHODS: Nude and nonobese diabetic-severe combined immunodeficiency (NOD-SCID) orthotopic mouse models were used, and S...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhu-Ling, Yu, Bin, Ning, Bo-Tao, Chan, Shing, Lin, Qiu-Bin, Li, James Chun-Bong, Huang, Jian-Dong, Chan, Godfrey Chi-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545364/
https://www.ncbi.nlm.nih.gov/pubmed/26286454
http://dx.doi.org/10.1186/s13045-015-0196-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545364/
https://www.ncbi.nlm.nih.gov/pubmed/26286454
http://dx.doi.org/10.1186/s13045-015-0196-3

Ejemplares similares